EDGAR Filing Documents for 0001723128-19-000107

Form 8-K - Current report:

SEC Accession No. 0001723128-19-000107

Filing Date

2019-08-05

Accepted

2019-08-05 06:20:20

Documents

Period of Report

2019-08-05

Items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	amrxq22019earningsrelease8.htm	8-K	28838
2	EXHIBIT 99.1	amrxq22019exhibit991.htm	EX-99.1	1359884
3		exhibit991892018image1a02.jpg	GRAPHIC	10129
	Complete submission text file	0001723128-19-000107.txt		1403977

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807

Business Address (908) 947-3120

Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 19997473
SIC: 2834 Pharmaceutical Preparations